NEW

Covera Health Announces Integration of AI for Breast Cancer Detection

Covera Health, the country’s leading provider of clinical analytics solutions to reduce medical misdiagnoses and improve healthcare quality, announced the integration of ScreenPoint Medical’s artificial intelligence (AI) tools into its quality analytics platform....

Carestream to Share Newest Additions at RSNA

Carestream Health will share its newest additions in digital radiography detectors and imaging software at the upcoming virtual Radiological Society of North America (RSNA) conference.

FDA Clears YSIO X.pree Intelligent Radiography System

Siemens Healthineers has announced Food and Drug Administration (FDA) clearance of the YSIO X.pree, a ceiling-mounted radiography system with the MyExam Companion intelligent user interface. “In addition to this easy-to-use interface that guides the radiologic...

Intermountain Healthcare, Sanford Health Plan Merger

Intermountain Healthcare and Sanford Health have signed a letter of intent to develop a strategic partnership. "Intermountain and Sanford have a shared vision of the future of health care and have the aligned values needed to better serve more communities across the...

Densitas Inc. Wins Major Procurement of Its AI-Powered Breast Density Software for DIMASOS Breast Screening Trial

HALIFAX, Nova Scotia, September 18, 2019 — Densitas Inc., a leading provider of AI solutions for digital mammography, announced today it has won a procurement of its densitas densityai™ software for deployment in up to twenty-four breast cancer screening clinics across Germany that will provide breast density measurements at point of care to identify women for supplemental breast cancer screening as part of the DIMASOS 2 Trial.

Prof. Dr. Sylvia H. Heywang-Köbrunner, M.D., Head of Referenzzentrum Mammographie München, internationally recognized for her pioneering work in contrast-enhanced breast MRI and modern biopsy procedures, is using densitas densityai™ breast density measures to establish a supplemental ultrasound screening protocol in the DIMASOS 2 trial.

“Women with dense breasts are subject to the masking effect of mammographic density and its association with breast cancer risk. The objective of the DIMASOS 2 trial is to test whether combined mammography/ultrasound exams can improve early cancer detection and if this can feasibly and cost effectively be done in routine screening workflow,” said Dr. Heywang-Köbrunner.  “The unique ability of the Densitas® software to analyze prior ‘for presentation’ mammograms from a wide range of mammography scanner vendor models is pivotal to this trial and is important for any practical clinical deployment.”

Densitas densityai™ delivers fully automated, standardized, and reproducible breast density assessments from standard DICOM clinical use mammograms. Results from densitas densityai™ are generated by two distinct algorithms that decouple the breast density assessment into quantitative and qualitative scales in alignment with the ACR BI-RADS 4th and 5th edition density classification systems. These results can be incorporated into breast cancer risk models to provide standardized and reproducible patient-specific risk estimates.

“Being selected as the vendor of choice to provide automated breast density assessment for the DIMASOS 2 Trial attests to our modern AI-driven technology superseding dated breast density algorithms developed prior to the introduction of the ACR BI-RADS 5th ed. density scale in 2013,” said Mo Abdolell, Densitas CEO.  “Densitas densityai™ processes the same clinical use images that radiologists examine, setting it apart by enabling seamless PACS-centric integrations and retrospective auditing capabilities of routinely archived exams.  This makes it an ideal fit for the DIMASOS 2 trial.  More broadly this also simplifies clinical deployments, and is more cost effective and deeply integrated into radiologist reporting workflows with key applications and platforms that include Nuance PowerScribe One and PowerScribe 360 Reporting, The Nuance AI Marketplace, Ikonopedia structured breast reporting and tracking software, TeraRecon’s AI interoperability platform, EnvoyAI, Blackford Platform and Curated Marketplace, and Three Palm Software’s WorkstationOne.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *